The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
A TODDLER given a “nightmare” diagnosis after catching a common childhood virus is asking Father Christmas for a life-saving heart transplant this Christmas. Little Willow Stansfield, ...
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination ...